New Scientific Findings and Their Impact on the Enderlein Perspective

New Scientific Findings and Their Impact on the Enderlein Perspective: "
New Scientific Findings and Their Impact on the Enderlein Perspective
� Copyright 2001 by Michael Coyle for NuLife Sciences, USA
(Explore Issue: Volume 10, Number 6)
This paper is written as a response to the recent findings on pleomorphism that have been presented by Ronald Ullmann, a biochemist who resides in Calw, Germany. The conclusions that are presented by Mr. Ullmann are based on the published research findings of Dr. Christopher Gerner, Ph.D. The paper itself may be located at http://www.bioresourceinc.com/articles/perspective.html
It should be noted that Mr. Ullmann is the son-in-law of the family that owns San-Pharma, a competitor in the field of isopathic remedies distribution and therefore should not at all be considered an unbiased or impartial source of research information. On the other hand, let's attempt to consider the matter rigorously.

Mycoplasma has the appearance of a donut or circle in the darkfield at 1,000X.
I would like to begin by saying that, if it proves to be true and replicable, I am very pleased that the research which is presented has led us to some possible conclusions regarding the works and theories of Prof. Dr. G�nther Enderlein, who was one of the earliest proponents of pleomorphic theory, and the developer of numerous remedies which are drawn from microorganisms or their by-products. This presentation will attempt to give a synopsis of these findings, and an interpretation of the practical ramifications for both the individuals interpreting the meaning of the Native Blood Analysis and the individual who is the subject of the evaluation or screening process.
One of the primary implications of the Gerner research is that the cycles of development introduced by Prof. Dr. Enderlein in his work entitled Ba"